Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Verastem Inc (VSTM)

Verastem Inc (VSTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Verastem: Q3 Earnings Snapshot AP - Wed Nov 6, 4:00PM CST

Verastem: Q3 Earnings Snapshot

VSTM : 4.01 (+5.80%)
Verastem: Q2 Earnings Snapshot AP - Thu Aug 8, 5:18PM CDT

Verastem: Q2 Earnings Snapshot

VSTM : 4.01 (+5.80%)
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments Newswire.ca - Wed Jun 12, 9:22AM CDT

/CNW/ -- After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovered that Generation X may...

RHHBY : 35.4650 (+0.95%)
ONCY : 0.9951 (-0.34%)
VSTM : 4.01 (+5.80%)
CADL : 4.15 (+4.27%)
FGEN : 0.3687 (+5.34%)
REGN : 747.56 (+0.57%)
ONC.TO : 1.38 (-1.43%)
The Fight Against Pancreatic Cancer: Biotech Firms Develop New Solutions for Rising Gen X Cases BayStreet.ca - Wed Jun 12, 9:11AM CDT

USA News Group – After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovered that Generation X may be experiencing larger per-capita...

ONCY : 0.9951 (-0.34%)
ONC.TO : 1.38 (-1.43%)
RHHBY : 35.4650 (+0.95%)
VSTM : 4.01 (+5.80%)
CADL : 4.15 (+4.27%)
FGEN : 0.3687 (+5.34%)
REGN : 747.56 (+0.57%)
Biotech Innovations Drive Pancreatic Cancer Treatment: Market Expected to Reach $7.4 Billion by 2032 BayStreet.ca - Mon Jun 3, 8:33AM CDT

USA News Group – Recognized as one of the most lethal cancers, researchers are striving to improve survival rates for pancreatic cancer patients by focusing on earlier detection. According to Johns Hopkins...

ONCY : 0.9951 (-0.34%)
ONC.TO : 1.38 (-1.43%)
VSTM : 4.01 (+5.80%)
CTMX : 0.8765 (+0.74%)
BNTX : 107.00 (+4.76%)
FGEN : 0.3687 (+5.34%)
Biotech Advances in 2024: Innovative Treatments Aim to Boost Pancreatic Cancer Survival Rates Newswire.ca - Mon Jun 3, 8:17AM CDT

/CNW/ -- USA News Group – Recognized as one of the most lethal cancers, researchers are striving to improve survival rates for pancreatic cancer patients by...

ONCY : 0.9951 (-0.34%)
VSTM : 4.01 (+5.80%)
CTMX : 0.8765 (+0.74%)
BNTX : 107.00 (+4.76%)
FGEN : 0.3687 (+5.34%)
ONC.TO : 1.38 (-1.43%)
Wall Street - shutterstock_93231562
Stock Index Futures Rebound from Thursday’s Sell-Off, U.S. Economic Data on Tap Barchart - Fri May 24, 4:36AM CDT

June S&P 500 E-Mini futures (ESM24) are up +0.28%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.30% this morning, rebounding from yesterday’s slump prompted by strong U.S. economic data, which...

ESM24 : 5,471.89s (-0.09%)
NQM24 : 19,747.29s (-0.08%)
GFS : 42.33 (+1.61%)
LYV : 138.86 (+1.72%)
BA : 143.46 (-1.79%)
NVDA : 147.76 (+1.28%)
DELL : 139.50 (+4.14%)
RNO.FP : 40.550 (-0.20%)
VSTM : 4.01 (+5.80%)
ROST : 142.10 (+2.00%)
MGNI : 16.49 (+2.87%)
DD : 82.88 (+1.26%)
Verastem: Q1 Earnings Snapshot AP - Thu May 9, 3:56PM CDT

Verastem: Q1 Earnings Snapshot

VSTM : 4.01 (+5.80%)
Verastem: Q4 Earnings Snapshot AP - Thu Mar 14, 3:53PM CDT

Verastem: Q4 Earnings Snapshot

VSTM : 4.01 (+5.80%)
Verastem: Q3 Earnings Snapshot AP - Wed Nov 8, 2023

Verastem: Q3 Earnings Snapshot

VSTM : 4.01 (+5.80%)

Barchart Exclusives

ELF’s Unusual Options Activity Is a Thing of Questionable Beauty Barchart - 1 hour ago
E.L.F. Beauty’s options volume on Wednesday was 7x the 30-day average. The affordable makeup and skincare company’s unusual options activity stood out as one investor questioned its revenues. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot